Home › Pheochromocytoma › NCT03160274
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * diagnosis of pheochromocytoma and or paraganglioma * family member with diagnosis of pheochromocytoma and or paraganglioma * diagnosis of a pheochromocytoma- and or paraganglioma-associated condition * family member with diagnosis of a pheochromocytoma- and or paraganglioma-associated condition Exclusion Criteria: * unconfirmed diagnosis of pheochromocytoma and/or paraganglioma or associated condition
About the study
Pheochromocytomas and paragangliomas are neural crest-derived tumors of the nervous system that are often inherited and genetically heterogeneous. Genetic screening is recommended for patients and their relatives, and can guide clinical decisions. However, a mutation is not found in all cases. The aims of this proposal are to: 1) to map gene(s) involved in pheochromocytoma, and 2) identify genotype-phenotype correlations in patients with pheochromocytoma/paraganglioma of various genetic origins.
What is being tested
- Genetic screening (genetic)
Sponsor: The University of Texas Health Science Center at San Antonio · Participants: 2,000 · Started: Oct 19, 2005
Contact the study team
- Patricia L Dahia, MD,PhD · Phone: 2105674866
Official record on ClinicalTrials.gov — NCT03160274
Locations in the U.S.
| Texas | University of Texas Health Science Center, San Antonio |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.